Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic resections and ENCODE-guided genomics to advance surgery and oncology

  • Letter to the Editor
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449. doi:10.1016/S1470-2045(10)70070-X

    Article  PubMed  Google Scholar 

  2. Sano T (2010) Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association. Gan To Kagaku Ryoho 37(4):582–586

    PubMed  Google Scholar 

  3. Katsios C, Baltogiannis G, Roukos DH (2011) Progress, challenges and new genome-based concepts in the multidisciplinary treatment of gastric cancer. Expert Rev Anticancer Ther 11(4):503–506. doi:10.1586/era.11.15

    Article  PubMed  Google Scholar 

  4. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339(6127):1546–1558. doi:10.1126/science.1235122

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. ENCODE Project Consortium, Dunham I, Kundaje A, Aldred SF et al (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57–74. doi:10.1038/nature11247

    Article  CAS  PubMed  Google Scholar 

  6. Zhao XF, Jeong O, Jung MR, Ryu SY, Park YK (2013) A propensity score-matched case-control comparative study of laparoscopic and open extended (D2) lymph node dissection for distal gastric carcinoma. Surg Endosc 27(8):2792–2800. doi:10.1007/s00464-013-2809-7

    Article  PubMed  Google Scholar 

  7. Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406. doi:10.1007/s00464-008-9796-0

    Article  PubMed  Google Scholar 

  8. Nikiteas N, Roukos D, Kouraklis G (2011) Robotic versus laparoscopic surgery: perspectives for tailoring an optimal surgical option. Expert Rev Med Dev 8(3):295–298. doi:10.1586/erd.11.15

    Article  Google Scholar 

  9. Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249(4):695–696 (author reply 697). doi:10.1097/SLA.0b013e31819f26e9

    Google Scholar 

  10. Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555. doi:10.1007/s00464-008-9869-0

    Article  CAS  PubMed  Google Scholar 

  11. Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350 (author reply 350). doi:10.1097/SLA.0b013e3181b1e890

    Google Scholar 

  12. Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651 (author reply 651). doi:10.1097/SLA.0b013e3181b970dd

    Google Scholar 

  13. Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22(5):1402–1404. doi:10.1007/s00464-008-9890-3

    Article  PubMed  Google Scholar 

  14. Roukos DH (2011) Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharma J 11(2):81–92. doi:10.1038/tpj.2010.81

    CAS  Google Scholar 

  15. Stamatoyannopoulos JA (2012) What does our genome encode? Genome Res 22(9):1602–1611. doi:10.1101/gr.146506.112.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Roukos DH (2013) Genome network medicine: innovation to overcome huge challenges in cancer therapy. Wiley Interdiscip Rev Syst Biol Med. doi:10.1002/wsbm.1254

    PubMed  Google Scholar 

  17. Roukos DH (2013) Genome network medicine: new diagnostics and predictive tools. Expert Rev Mol Diagn 13(7):643–646. doi:10.1586/14737159.2013.820540

    Article  CAS  PubMed  Google Scholar 

  18. Roukos DH, Baltogiannis GG, Katsouras CS, Bechlioulis A, Naka KK, Batsis C, Liakakos T, Michalis LK (2014) Novel next-generation sequencing and networks-based therapeutic targets: realistic and more effective drug design and discovery. Curr Pharm Des 20(1):11–22. doi:10.2174/13816128113199990385

    Article  CAS  PubMed  Google Scholar 

  19. Roukos D (2013) Integrative deep-sequencing analysis of cancer samples: discoveries and clinical challenges. Pharmacogenomics J 13(3):205–208. doi:10.1038/tpj.2012.51

    Google Scholar 

  20. Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices 7(6):723–726

    Google Scholar 

  21. Roukos DH (2011) Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18(1):12–15

    Google Scholar 

  22. Roukos DH (2011) Chromatin: a key player in complex gene regulation and future cancer therapeutics. Epigenomics 3(4):395–399

    Google Scholar 

  23. Roukos DH (2011) Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions. Pharmacogenomics 12(5):695–698

    Google Scholar 

  24. Roukos DH (2011) Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets. Expert Rev Med Devices 8(2):123–126

    Google Scholar 

  25. Roukos DH (2011) “Big” science: genome regulatory networks and novel molecular tools to improve health. Expert Rev Mol Diagn 11(2):123–126

    Google Scholar 

  26. Roukos DH (2011) Translating epigenetics into an anticancer drug pipeline for solid tumors. Expert Rev Med Devices 8(4):409–413

    Google Scholar 

  27. Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280 author reply e282–e283

    Google Scholar 

  28. Roukos DH (2012) Spatiotemporal individual genome code-lifestyle network: revolutionizing personal diagnostics. Expert Rev Mol Diagn 9(3):215–218

    Google Scholar 

  29. Roukos DH (2012) Differential signalling transduction networks for clinical robustness. Expert Rev Proteomics 9(2):111–114

    Google Scholar 

  30. Roukos DH (2012) Biotechnological, genomics and systems-synthetic biology revolution: redesigning genetic code for a pragmatic systems medicine. Expert Rev Med Devices 9(2):97–101

    Google Scholar 

  31. Roukos DH (2012) Longevity with systems medicine? Epigenome, genome and environment interactions network. Epigenomics 4(2):119–123

    Google Scholar 

  32. Roukos DH (2012) Disrupting cancer cells’ biocircuits with interactome-based drugs: is ‘clinical’ innovation realistic? Expert Rev Proteomics 9(4):349–353

    Google Scholar 

  33. Ku CS, Roukos DH (2013) From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine. Expert Rev Med Devices 10(1):1–6. doi:10.1586/erd.12.63

    Google Scholar 

  34. Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B (2012) Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol 25(8):1055–1068. doi:10.1038/modpathol.2012.62

    Google Scholar 

  35. Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, Mort M, Cooper DN (2013) A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry 8(2):141–153. doi:10.1038/mp.2012.58

    Google Scholar 

  36. Ku CS, Cooper DN, Iacopetta B, Roukos DH (2013) Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clin Genet 83(1):2–6. doi:10.1111/cge.12028

    Google Scholar 

  37. Ku CS, Cooper DN, Roukos DH (2013) Clinical relevance of cancer genome sequencing. World J Gastroenterol 19(13):2011–2018. doi:10.3748/wjg.v19.i13.2011

    Google Scholar 

Download references

Disclosures

Christof Hottenrott declares that he has no conflict of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Chirurgische Klinik, St. Elisabethenkrankenhaus, Ginnheimer Straße 3, 60487, Frankfurt, Germany

    Christof Hottenrott

Authors
  1. Christof Hottenrott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christof Hottenrott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hottenrott, C. Laparoscopic resections and ENCODE-guided genomics to advance surgery and oncology. Surg Endosc 28, 2244–2246 (2014). https://doi.org/10.1007/s00464-014-3456-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-014-3456-3

Keywords

Search

Navigation